BioSpace News Archive

Amphista Therapeutics, a leader in next generation targeted protein degradation approaches, announced a Series B extension investment by the Dementia Discovery Fund.

MRM Health announced that its Type-2 Diabetes Program, developed in collaboration with IFF has achieved preclinical development targets.

Ascentage Pharma announced that it has released preliminary results from a global Phase II study of lisaftoclax, a key member of the company’s apoptosis-targeting pipeline, as a monotherapy or in combination with CALQUENCE® or rituximab in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma, in an oral presentation at the ASH 64th Annual Meeting & Exposition.

Soricimed Biopharma Inc., a clinical stage company focused on the development and commercialization of first-in-class targeted cancer therapeutics, has appointed Dr. Siqing Fu, a North American leader in cancer research, to its Scientific Advisory Board.

Biosion USA, Inc., a global R&D biotechnology company, announced an exploratory research collaboration to create antibody-drug conjugates for the treatment of cancer with ImmunoGen, Inc., a leader in developing next generation ADCs.

Nordic Nanovector ASA’s largest shareholder North Energy ASA, that now holds 11,518,448 shares in the Company, has requested that the Board of Directors calls for an Extraordinary General Meeting in accordance with the Norwegian Public Limited Liability Companies Act §5-7.

QIAGEN has announced the U.S. Food and Drug Administration approval of its therascreen® KRAS RGQ PCR kit as a companion diagnostic test to Mirati Therapeutic’s drug KRAZATI® for non-small cell lung cancer.

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announces that the Company’s Board of Directors has approved a first-quarter 2023 dividend of $0.19 per share.

MediWound Ltd., a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, announced it has gained marketing approval of NexoBrid® in India.

Rockwell Medical, Inc., a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company is adding new business within the Minnesota region.